New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma April 29, 2025 New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
Epigenetic weaknesses discovered in liver cancer capable of improving its treatment May 16, 2023 Epigenetic weaknesses discovered in liver cancer capable of improving its treatment
Researcher Salvador Macip joins the Josep Carreras Leukaemia Research Institute May 12, 2023 Researcher Salvador Macip joins the Josep Carreras Leukaemia Research Institute
Genomic studies gain importance in the diagnosis of new generation in hematologic cancer May 10, 2023 Genomic studies gain importance in the diagnosis of new generation in hematologic cancer
The President of the Government of Spain, Pedro Sánchez, visits the Josep Carreras Institute and praises its research against cancer May 05, 2023 The President of the Government of Spain, Pedro Sánchez, visits the Josep Carreras Institute and praises its research against cancer
Launch of a clinical trial with CAR-T against lymphoma, developed by Dr. Briones, member of the Josep Carreras Institute May 03, 2023 Launch of a clinical trial with CAR-T against lymphoma, developed by Dr. Briones, member of the Josep Carreras Institute
The researcher Ainara Meler receives the award for the best scientific publication in immunology April 28, 2023 The researcher Ainara Meler receives the award for the best scientific publication in immunology
Researchers find out why some lung tumors avoid immunotherapy and how to predict it in advance April 14, 2023 Researchers find out why some lung tumors avoid immunotherapy and how to predict it in advance
The Catalan Minister of Health, Manel Balcells, visits the Josep Carreras Institute April 13, 2023 The Catalan Minister of Health, Manel Balcells, visits the Josep Carreras Institute
The CarrerasLeaders Call is Open: a new Postdoctoral Program to empower Future Leaders to Fight Blood Cancers March 23, 2023 The CarrerasLeaders Call is Open: a new Postdoctoral Program to empower Future Leaders to Fight Blood Cancers
The Josep Carreras Leukaemia Research Institute, first center accredited in Visum Spatial Transciptomics by 10x Genomics March 21, 2023 The Josep Carreras Leukaemia Research Institute, first center accredited in Visum Spatial Transciptomics by 10x Genomics
.png?locale=en)
